The most read stories of 2019 on the Michigan Health Lab blog.

Eye doctors reduce number of prescription opioids after cornea surgery with no negative impact on pain management.

A Michigan Medicine Kellogg Eye Center ophthalmology course provides hands-on learning to help prepare medical students transitioning into residency.

Gene therapy may prevent blindness from rare eye disease Leber congenital amaurosis.

Kellogg Eye Center ophthalmologists explain which vitamins and supplements are actually good for your eyes.

Now with recreational marijuana legalized in Michigan, it’s easier for glaucoma patients to substitute traditional treatment methods for a joint. But does it..

Genetic Origin of Severe Developmental Eye Condition Identified

Firework Hits Child in the Face, Mother Urges Caution

Metro Detroit TV Weatherman Dave Rexroth stays active, independent despite fireworks accident that left him with single vision.

Success of phase 3 trial evaluating teprotumumab for treatment of active thyroid eye disease (TED) brings drug closer to FDA approval.

The genetic disease that causes vision loss can affect all ages, including young people. Learn more about symptoms, risk factors and management.

A patient’s electronic health record may not capture the most accurate, up-to-date information about ophthalmic medications, a new study finds.

A review of patient data finds a potential link to costly diabetic eye treatments. It also underscores the need for collaborative care.

Large Kellogg Eye Center study shows cases of herpes zoster ophthalmicus tripled in 12 year time span, highest among older adults

Pairing a smartphone to capture retinal images with artificial intelligence to interpret them may help overcome barriers to ophthalmic screening for the disease.